All In Biotech

Drug Trial Radar · NCT04083339

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure (ARISE-HF): A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Last checked: Nov 19, 2026Latest source record: Dec 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 675 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

675

Planned (sponsor's estimate)

Start

Sep 20, 2019

Primary completion

Dec 2023

Study completion Dec 2025

Sponsor

Lead sponsor
Applied Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 10, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.

Conditions

  • Diabetic Cardiomyopathies

Interventions

  • AT-001Drug

    AT-001 will be administered as 3 capsules twice daily, before breakfast and before dinner. At present AT001 is the sole name for the active substance. No INN/genetic name is available to date

  • PlaceboDrug

    Matching placebo will be administered as 3 capsules twice daily, before breakfast and before dinner

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak VO2 during cardio-pulmonary exercise test (CPET);Time frame: 15 months after randomization]

Locations

79 sites in 10 countries. Site status is shown where the registry gives one.

  • Westside Medical Associates of Los Angeles

    Beverly Hills, California

  • University of California, San Diego (UCSD)

    La Jolla, California

  • Clinical Trials Research

    Lincoln, California

  • University of California - Irvine Medical Center

    Orange, California

  • Metabolic Institute of America

    Tarzana, California

  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center

    Torrance, California

  • ALL Medical Research, LLC

    Cooper City, Florida

  • New Generation of Medical Research

    Hialeah, Florida

  • Broward Research Center

    Pembroke Pines, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • UnityPoint Health - Methodist Hospital

    Peoria, Illinois

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Universty of Mississippi Medical Center

    Jackson, Mississippi

  • St. Louis Heart and Vascular Cardiology

    St Louis, Missouri

  • Chear Center LLC

    The Bronx, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Remington Davis, Inc.

    Columbus, Ohio

  • South Oklahoma Heart Research

    Oklahoma City, Oklahoma

  • Mountain View Clinical Research - Greer

    Greer, South Carolina

  • Mountain View Clinical Research

    Greer, South Carolina

  • Holston Medical Group

    Kingsport, Tennessee

  • Dallas Diabetes Research Center

    Dallas, Texas

  • Southwest Family Medicine Associates

    Dallas, Texas

  • University of Texas Southwestern

    Dallas, Texas

  • Juno Research, LLC - Northwest Site

    Houston, Texas

  • Juno Research, LLC - Southwest Houston Site

    Houston, Texas

  • FMC Science

    Lampasas, Texas

  • Prince Charles Hospital

    Chermside, Queensland, Australia

  • CORE Research Group Pty. Ltd.

    Milton, Queensland, Australia

  • AusTrials

    Taringa, Queensland, Australia

  • University of Tasmania at Hobart

    Hobart, Tasmania, Australia

  • Barwon Health-University Hospital Geelong

    Geelong, Victoria, Australia

  • Austin Health

    Heidelberg, Victoria, Australia

  • Baker Heart and Diabetes Institute

    Melbourne, Victoria, Australia

  • C-Endo - Endocrinology Centre

    Calgary, Alberta, Canada

  • BC Diabetes

    Vancouver, British Columbia, Canada

  • LMC Diabetes & Endocrinology Ltd. - Brampton

    Brampton, Ontario, Canada

  • LMC Diabetes & Endocrinology Ltd. - Thornhill

    Concord, Ontario, Canada

  • LMC Diabetes & Endocrinology Ltd. - Etobicoke

    Etobicoke, Ontario, Canada

Showing 40 of 79 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.